# Revisiting health rights litigation and access to medications in Costa Rica: preliminary evidence from the Cochrane Collaboration reform

Source: https://onco.cc/key-papers/paper-loaiza-sala-iv-medicines-litigation-costa-rica-hhr-2018/  
OnCo record `paper-loaiza-sala-iv-medicines-litigation-costa-rica-hhr-2018` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

In 2014 Costa Rica's constitutional court began a partnership with the Cochrane Collaboration to bring medical expert evaluations into its rulings on claims for medicines; afterwards claimants won more often, and a smaller share of rulings granted experimental medicines.

## Summary

Costa Rica's constitutional chamber of the Supreme Court, the Sala IV, built an expansive right to health that led to a large volume of litigation for medicines, criticised for placing the right above the finances of the state health system. In 2014 the court began a partnership with the Cochrane Collaboration to bring medical expert evaluations into its decisions on medicine claims. The authors reviewed all medicine claims from 2016, classified the successful ones by standard priority-setting criteria and compared them with 2008 rulings.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: Health and Human Rights
- Year: 2018
- Authors: Loaiza OR, Morales S, Norheim OF, Wilson BM
- Findings: An earlier study found more than 70% of favourable rulings were for low-priority medications.; Under the reformed process the probability of winning a medication lawsuit increased significantly.; The share of rulings granting experimental medicines declined and the share granting high-priority medicines increased.
- What it means: In Costa Rica a patient refused a medicine by the public system can go to the constitutional court, and since a 2014 reform the court draws on medical expert evaluations in these cases.
- Caveats: The authors call their conclusion tentative and the gains in fairness minor.; Not specific to cancer medicines.

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/30008554/
- PubMed Central full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039739/

## Connected records

- institutions: [Caja Costarricense de Seguro Social (CCSS)](https://onco.cc/institutions/ccss-costa-rica/)

---
JSON: https://onco.cc/api/v1/entities/paper-loaiza-sala-iv-medicines-litigation-costa-rica-hhr-2018.json